rs61741336
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_172364.5(CACNA2D4):c.3065C>T(p.Pro1022Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00949 in 1,585,220 control chromosomes in the GnomAD database, including 115 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_172364.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA2D4 | NM_172364.5 | c.3065C>T | p.Pro1022Leu | missense_variant | 35/38 | ENST00000382722.10 | NP_758952.4 | |
CACNA2D4 | XM_011521041.3 | c.3002C>T | p.Pro1001Leu | missense_variant | 34/36 | XP_011519343.1 | ||
CACNA2D4 | XM_047429897.1 | c.2993C>T | p.Pro998Leu | missense_variant | 34/36 | XP_047285853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D4 | ENST00000382722.10 | c.3065C>T | p.Pro1022Leu | missense_variant | 35/38 | 1 | NM_172364.5 | ENSP00000372169.4 | ||
CACNA2D4 | ENST00000586184.5 | c.3065C>T | p.Pro1022Leu | missense_variant | 35/37 | 5 | ENSP00000465060.1 | |||
CACNA2D4 | ENST00000587995.5 | c.2990C>T | p.Pro997Leu | missense_variant | 34/37 | 5 | ENSP00000465372.1 | |||
CACNA2D4 | ENST00000585708.5 | c.2873C>T | p.Pro958Leu | missense_variant | 35/37 | 5 | ENSP00000467697.1 | |||
CACNA2D4 | ENST00000588077.5 | c.2873C>T | p.Pro958Leu | missense_variant | 35/38 | 5 | ENSP00000468530.1 | |||
CACNA2D4 | ENST00000536846.6 | c.503C>T | p.Pro168Leu | missense_variant | 9/12 | 5 | ENSP00000468167.1 | |||
CACNA2D4 | ENST00000538027.6 | c.500C>T | p.Pro167Leu | missense_variant | 9/12 | 5 | ENSP00000443038.2 | |||
CACNA2D4 | ENST00000538450.5 | c.455C>T | p.Pro152Leu | missense_variant | 8/11 | 2 | ENSP00000446341.1 | |||
CACNA2D4 | ENST00000444595.6 | n.*1249C>T | non_coding_transcript_exon_variant | 34/37 | 1 | ENSP00000403371.2 | ||||
CACNA2D4 | ENST00000537784.5 | n.*258C>T | non_coding_transcript_exon_variant | 12/15 | 1 | ENSP00000440231.2 | ||||
CACNA2D4 | ENST00000545595.6 | n.*258C>T | non_coding_transcript_exon_variant | 7/10 | 1 | ENSP00000442329.2 | ||||
CACNA2D4 | ENST00000585385.5 | n.*258C>T | non_coding_transcript_exon_variant | 8/11 | 5 | ENSP00000467333.1 | ||||
CACNA2D4 | ENST00000444595.6 | n.*1249C>T | 3_prime_UTR_variant | 34/37 | 1 | ENSP00000403371.2 | ||||
CACNA2D4 | ENST00000537784.5 | n.*258C>T | 3_prime_UTR_variant | 12/15 | 1 | ENSP00000440231.2 | ||||
CACNA2D4 | ENST00000545595.6 | n.*258C>T | 3_prime_UTR_variant | 7/10 | 1 | ENSP00000442329.2 | ||||
CACNA2D4 | ENST00000585385.5 | n.*258C>T | 3_prime_UTR_variant | 8/11 | 5 | ENSP00000467333.1 |
Frequencies
GnomAD3 genomes AF: 0.00664 AC: 1011AN: 152194Hom.: 4 Cov.: 34
GnomAD3 exomes AF: 0.00850 AC: 1756AN: 206662Hom.: 21 AF XY: 0.00950 AC XY: 1069AN XY: 112514
GnomAD4 exome AF: 0.00979 AC: 14027AN: 1432908Hom.: 111 Cov.: 32 AF XY: 0.0102 AC XY: 7271AN XY: 710932
GnomAD4 genome AF: 0.00663 AC: 1010AN: 152312Hom.: 4 Cov.: 34 AF XY: 0.00641 AC XY: 477AN XY: 74470
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 11, 2014 | - - |
Retinal cone dystrophy 4 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 09, 2021 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at